期刊文献+

羟苯基维胺脂对顺铂抗卵巢癌活性影响的研究

Effect of 4-HPR enhancing anti-cancer efficancy of cisplatin to ovarian cancer
原文传递
导出
摘要 目的:探讨羟苯基维胺脂(4-HPR)联合顺铂(DDP)对卵巢癌SKOV3细胞形态学、增殖、凋亡和细胞周期的影响,及其与血管内皮生长因子(VEGF)、尿激酶型纤溶酶原激活物(u-PA)表达变化的关系。方法:观察不同浓度4-HPR对SKOV3细胞形态学变化;MTT法检测4-HPR、DDP及联合对SKOV3细胞增殖的影响;流式细胞仪检测4-HPR、DDP对SKOV3细胞凋亡和细胞周期的影响;RT-PCR法检测4-HPR、DDP对SKOV3细胞VEGF、u-PAmRNA表达的影响。结果:1μmol/L的DDP对SKOV3细胞增殖抑制作用较弱,≥5μmol/LDDP可明显抑制SKOV3细胞增殖,P<0.05。1μmol/L的4-HPR对SKOV3细胞生长抑制作用不明显,≥2.5μmol/L时,4-HPR对SKOV3细胞生长抑制作用明显增强,P<0.05。5μmol/L的DDP联合4-HPR(1、5和10μmol/L)能显著抑制SKOV3细胞的增殖,两者联合对SKOV3细胞的抑制作用较DDP单独用药明显增强,P<0.05。不同浓度4-HPR和DDP作用SKOV3细胞48h均可诱导细胞凋亡并将细胞阻滞于G2~M期和S期,在两者联合时上述作用更加明显,P<0.05。不同浓度4-HPR和DDP作用SKOV3细胞48h均可抑制细胞VEGF、u-PAmRNA的表达,P<0.01。结论:4-HPR联合DDP能抑制卵巢癌SKOV3细胞增殖,诱导细胞凋亡,阻滞细胞周期,其机制可能与抑制VEGF、u-PA表达有关。 OBJECTIVE: To study the effect of 4-HPR combined with DDP on morphological changes, proliferation, apoptosis and cell cycle of human ovarian cancer SKOV3 cells and its relationship with VEGF and u-PA expressions. METHODS: The effect of 4-HPR on morphological changes of SKOV3 cell was observed by an optical microscope. The effect of 4-HPR and DDP on SKOV3 cell proliferation was measured by MTT assay. The cell apoptosis and cell cycle were analyzed by flow cytometry (FCM). The VEGF and u-PA mRNA expressions of SKOV3 cells were detected by RT-PCR analysis. RESULT: One vmol/L of DDP had weak inhibitory effect on SKOV3 cells, more than 5 μmol/L of DDP had remarkable inhibitory effect on SKOV3 Cell (P〈0.05). One μmol/L of 4-HPR had uneonspieuous inhibitory effect on SKOV3 cell, and more than 2.5 /μmol/L 4-HPR had distinct inhibitory effect on SKOV3 cell (P〈 0. 05). Five μmol/L of DDP combined with 4-HPR (1,5 and 10μmol/L) significantly inhibited the proliferation of ovarian cancer SKOV3 cells, which had a statistical difference compared with the DDP single medication group (P〈 0.05). 4-HPR combined with DDP induced cell apoptosis and arrested SKOV3 cell at G2-M and S stage compared with the control and 4-HPR, DDP used alone groups (P 〈 0.05). 4-HPR combined with DDP decreased the expressions of VEGF and u-PA mRNA compared with the control and 4-HPR, DDP used alone groups (P%0.01). CONCLUSION: 4-HPR combined with DDP can significantly inhibit the proliferation, induce apoptosis, and block cell cycle of ovarian cancer SKOV3 cells, which is associated with the VEGF and u-PA expressions.
作者 李文学 孙红
出处 《中华肿瘤防治杂志》 CAS 2009年第16期1229-1233,共5页 Chinese Journal of Cancer Prevention and Treatment
关键词 卵巢肿瘤 芬维A铵 顺铂 细胞凋亡 细胞周期 血管内皮生长因子类 ovarian neoplasms fenr etinide patincisl apoptosis cell cycle vascular endothelial growth factors
  • 相关文献

参考文献13

  • 1Tiwari M, Kumar A, Sinha R A, et al. Mechanism of 4-HPR-induced apoptosis in glioma cells: evidences suggesting role of mitochondrial-mediated pathway and endoplasmic reticulum stress[J]. Carcinogenesis,2006, 27(10) : 2047 -2058.
  • 2Veronesi U, Mariani L, Decensi A, et al. Fifteen-year results of a randomized phase Ⅲ trial of fenretinide to prevent second breast cancer[J]. Ann Oncol, 2006, 17(7):1065-1071.
  • 3Brewer M, Wharton J T, Wang J, et al. In vitro model of normal, immortalized ovarian surface epithelial and ovarian cancer cells for chemoprevention of ovarian cancer[J]. Gynecol Oncol, 2005, 98(2) :182-192.
  • 4Brewer M A, Johnson K, Follen M, et al. Prevention of ovarian cancer: intraepithelial neoplasia[J]. Clin Cancer Res, 2003, 9(1) : 20-30.
  • 5尹凤玲,陆静,李爱萍,顾灯安,韩素萍,周建伟.4-HPR联合DDP对HeLa细胞的增殖和凋亡作用[J].癌变.畸变.突变,2006,18(3):214-217. 被引量:6
  • 6Hailjr N, Kim H J, Lotan R. Mechanisms of fenretinide-induced apoptosis[J]. Apoptosis, 2006,11(10) :1677 -1694.
  • 7Brewer M, Kirkpatrick N D, Wharton J T, et al. 4-HPR modu lates gene expression in ovarian cells[J].Int J Cancer, 2006, 119(5) :1005- 1013.
  • 8Chiesa F, Tradati N, Grigolato R, et al. Randomized trial of fenretinide (4-HPR) to prevent recurrences, new localizations and carcinomas in patients operated on for oral leukoplakia: Long -term results[J]. Int J Cancer,2005,115 (4): 625-629.
  • 9Formelli F, Cleris L. Therapeutic effects of the combination of fenretinide and all-trans-retinoic acid and of the two retinoids with cisplatin in a human ovarian carcinoma xenograft and in a cisplatin-resistant subline[J].Eur J Cancer, 2000, 36(18):2411-2419.
  • 10Whitley B R, Beaulieu L M, Carter J C, et al. Phosphatidylinositol 3 kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells[J].Gynecol Oncol, 2007,104(2):470-479.

二级参考文献15

  • 1吴唯,吕新生,唐中华,张翼,李小荣,陈道瑾.乳腺癌组织中VEGF mRNA的表达及其临床意义[J].中国普通外科杂志,2004,13(11):813-816. 被引量:5
  • 2曹泽毅.子宫颈癌治疗的变迁和思考[J].现代妇产科进展,2005,14(1):1-5. 被引量:26
  • 3唐金海,赵建华,徐甫保,秦建伟,龚建平.肿瘤切除和术后复发对乳腺癌患者血管生成平衡的影响[J].中国普通外科杂志,2005,14(9):672-675. 被引量:1
  • 4Hail N J, Lotan R. Mitochondrial respiration is uniquely associated with the prooxidant and apoptotic effects of N-(4-hydroxyphenyl)retinamide[J]. Bio Chem, 2001 276(49) :45 614- 45 621.
  • 5Frei E. Clinical cancer research: an embatded species[J].Cancer,1982 ,50 (10):1 979- 1 992.
  • 6Shimada K, Nakamura M,Isida E, et al. Requirement of c-jun for testosterone-induced sensitization to N-(4-hydroxyphenyl)retinamide-induced apoptosis[J]. Mol Carcinog, 2003 , 36(3) :115- 122.
  • 7Takahashi N, Ohba T, Togashi S, et al. Biological activity of p-methyl-aminophenol, an essential structural component of N-(4-hydroxyphenyl) retinamide, fenretinide[J] . Biochem, 2002 ,132(5) :767 - 774.
  • 8Yu J,Bian D,Mahanivong C,et al.p38 Mitogen-activated protein kinase regulation of endothelial cell migration depends on urokinase plasminogen activator expression[J].J Biol Chem,2004,279(48):50446 -50454.
  • 9Dano K,Andreason PA,Grondahl-Hansen K,et al.Plasminogen activators,tissue degradation and cancer[J].Adv Cancer Res,1985,44(2):139 -266.
  • 10Neufeld G,Tessler S,Weindel K,et al.vascular permeability factor and its receptors[J].Prog Growth Factor Res,1994,5(1):89 -97.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部